Revista Ciencias Biomédicas (Jan 2015)
EFFICACY OF THE LAPAROSCOPIC SLEEVE GASTRECTOMY
Abstract
Introduction: the obesity is a disease with high impact in mortality and morbidity worldwide, for which, the bariatric surgery is currently the most effective treatment in the indicated cases. The laparoscopic sleeve gastrectomy (LSG) has been consolidated as an intervention widely done due to positive reports in the loss of weight and evolution of comorbidities, with the own advantages of the minimally invasive surgery. Nevertheless, there are series that differ from these results, while others debate their safety. Objective: To determine the efficacy of the sleeve gastrectomy in the reduction of weight and resolution of associated diseases. Methods: a prospective and descriptive study was carried out in all the patients who attended to sleeve gastrectomy surgery in the Hospital Universitario del Caribe, Cartagena, Colombia. Clinical variables related with the preoperative nutritional status and three months postoperative until the 12 months were measured. The efficacy was defined as the proportion of weight loss, in addition, the resolution criteria or improvement of the comorbidities were defined according to the internationally accepted guidelines. Results: 39 LSG were carried out. The majority of patients were women (86.4%), with an average age of 40 ± 11 years. The average of loss of excess weight was 68.2%. The 66.6%, 64.28% and 72.71% of the patients with diabetes mellitus, arterial hypertension and dyspnea respectively, presented resolution or improvement of their comorbidity. There were not found complications nor deaths Conclusions: The LSG (“tubular” or “vertical”) is a relatively safe and effective surgery in terms of loss of weight, evolution of the comorbidities, complications and mortality. More studies are needed by long-term follow-up. Rev.cienc.biomed. 2015;6(1):45- 52 KEYWORDS Bariatric surgery; Morbid obesity; Gastrectomy; Laparoscopy.
